ISO 27001 provides this framework, ensuring the confidentiality, integrity, and availability of information throughout the organization. By achieving this certification, Medicover Genetics Cyprus demonstrates that it has implemented robust controls and a risk-based approach to information security, aligned with international best practices.

“This certification reflects our broader commitment to building a secure and resilient organization,” said Dr. Marios Ioannides, Managing Director at Medicover Genetics Cyprus. “In today’s digital environment, information security is fundamental to maintaining trust. It requires continuous oversight, strong governance, and a culture of accountability across the organization.”

The certification is the result of a coordinated, cross-functional effort, involving multiple teams and departments. It highlights the organization’s ability to integrate security into its operations while supporting innovation and service delivery.

Beyond regulatory alignment, ISO 27001 certification strengthens trust with patients, partners, and stakeholders. It positions Medicover Genetics Cyprus as a reliable and secure provider in the field of genetic testing, capable of managing evolving cybersecurity risks while supporting ongoing digital transformation.

Medicover Genetics Cyprus remains committed to continuously improving its information security practices, ensuring that security, compliance, and operational excellence remain central to its growth strategy.